Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 161.00K | 160.30K | 158.90K |
| Total Other Revenue | 10.40M | 10.02M | 9.42M | 9.33M | 9.04M |
| Total Revenue | 10.40M | 10.02M | 9.58M | 9.49M | 9.20M |
| Cost of Revenue | 7.87M | 7.57M | 7.42M | 7.50M | 7.74M |
| Gross Profit | 2.53M | 2.44M | 2.17M | 1.99M | 1.46M |
| SG&A Expenses | 2.27M | 3.24M | 2.52M | 2.26M | 4.02M |
| Depreciation & Amortization | 362.70K | 374.10K | 409.50K | 423.60K | 430.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.50M | 11.19M | 10.35M | 10.19M | 12.20M |
| Operating Income | -97.30K | -1.17M | -763.90K | -696.30K | -2.99M |
| Income Before Tax | -576.50K | -1.61M | 794.30K | -1.03M | -3.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -576.50K | -1.61M | 794.30K | -1.03M | -3.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -576.50K | -1.61M | 794.30K | -1.03M | -3.63M |
| EBIT | -97.30K | -1.17M | -763.90K | -696.30K | -2.99M |
| EBITDA | 265.50K | -797.60K | -354.40K | -272.70K | -2.56M |
| EPS Basic | -0.19 | -0.53 | 0.26 | -0.34 | -1.19 |
| Normalized Basic EPS | -0.13 | -0.33 | -0.27 | -0.21 | -0.78 |
| EPS Diluted | -0.20 | -0.53 | 0.26 | -0.34 | -1.20 |
| Normalized Diluted EPS | -0.13 | -0.33 | -0.27 | -0.21 | -0.78 |
| Average Basic Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.05M |
| Average Diluted Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 0.00% |